Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dust metagenome

ABSTRACT: Bacteria Genome sequencing

PROVIDER: PRJNA356963 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5247670_1.fastq.gz	Fastqsanger.gz
	SRR5247670_2.fastq.gz	Fastqsanger.gz
	SRR5247680_1.fastq.gz	Fastqsanger.gz
	SRR5247680_2.fastq.gz	Fastqsanger.gz
	SRR5247690_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 62

Similar Datasets

dust metagenome

Project description:Culturable house dust-borne bacteria raw sequence reads

| PRJNA302236 | ENA

dust metagenome

Project description:di-2-ethylhexyl phthalate in dust and bacteria

| PRJNA541585 | ENA

dust metagenome

Project description:Metagenomic analysis of odor-causing bacteria in automobile air conditioning systems

| PRJNA343407 | ENA

dust metagenome

Project description:HVAC Filter samples Genome sequencing

| PRJNA356365 | ENA

dust metagenome

Project description:ITS sequencing of house dust samples

| PRJDB9891 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Storm dust

Project description:Biogeochemical cycles and health implications potentially mediated by bioactive dust-borne bacteria

| PRJNA982604 | ENA